Protective role of probiotics and prebiotics in colon cancer

American Journal of Clinical Nutrition

Volumn 73, Issue 2 SUPPL., 2001, Pages

  Wollowski, I ^a   Rechkemmer, G ^a   Pool Zobel, B L ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antigenotoxicity; Butyrate; Colon cancer; Fermentation; Lactic acid bacteria; Microflora; Prebiotics; Probiotics; Protective mechanisms; Short chain fatty acids

Indexed keywords

BUTYRIC ACID; CARCINOGEN; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; NITROSAMINE; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID;

CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; CONFERENCE PAPER; DETOXIFICATION; FERMENTATION; GENE MUTATION; HUMAN; INTESTINE FLORA; LACTIC ACID BACTERIUM; NONHUMAN;

LACTOBACILLUS BULGARICUS; STREPTOCOCCUS THERMOPHILUS;

EID: 0035151198     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/73.2.451s     Document Type: Conference Paper

References (68)

1. Lactic acid bacteria as promoters of human health
2. Lebendkeime in fermentierten milchprodukten - Ihre bedeutung für die prophylaxe und therapie
3. Colonic microflora: Nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI) [Europe] workshop held in Barcelona, Spain
4. Effects of lactulose and lactitol on colonic microflora and enzymatic activity
5. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans
6. Fecal numbers of bifidobacteria are higher in pigs fed Bifidobacterium longum with a high amylose cornstarch than with a low amylose cornstarch
7. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal shortchain fatty acids, pH and microflora in rats
8. Modification of the intestinal microflora using probiotics and prebiotics
9. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection
10. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats
11. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats
12. The effect of Lactobacillus GG on the initiation and promotion of DMH-induced intestinal tumors in the rat
13. Effect of Lactobacillus acidophilus dietary supplements on 1,2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats
14. Fermented dairy products, calcium, and colorectal cancer in the Netherlands cohort study
15. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men
16. Dietary factors in a study of cancer colon from cancer registry, with special reference to the role of saliva, milk and fermented milk products and vegetable fibre
17. Case-control study of proximal and distal colon cancer and diet in Wisconsin
18. Diet and colon cancer in Los Angeles County, California
19. Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: A French case-control study
20. Antigenotoxic properties of lactic acid bacteria in the S. typhimurium mutagenicity assay
21. Antimutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus bulgaricus
22. Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats
23. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats
24. Untersuchungen zu protektiven Wirkungen von Bakterienmetaboliten auf molekulare Prozesse der Kolonkarzinogenese
25. Untersuchungen zur Klärung der Mechanismen bei antigenotoxischen und antikanzerogenen Wirkungen durch Milchsäurebakterien: Charakterisierung von bakteriellen Zellfraktionen für die Entgiftung von lebensmittelrelevanten Kanzerogenen
26. The effect of milk and lactobacillus feeding on human intestinal bacterial enzyme activity
27. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract
28. Impact of Bifidobacterium longum on human fecal microflora
29. Effects of Bifidobacterium sp fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans
30. In vitro binding of potent mutagenic pyrolysates
31. In vitro binding of mutagenic pyrolyzates to lactic acid bacterial cells in human gastric juice
32. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria
33. Effect of Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in humans
34. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake
35. Fecal short chain fatty acids in South African urban Africans and whites
36. Dietary fibre, non-starch polysaccharides and resistant starch - A review
37. Apoptosis in colorectal tumour cells: Induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate
38. Deoxycholic acid and SCFA-induced apoptosis in the human tumor cell-line HT-29 and possible mechanisms
39. Lack of butyrate is associated with induction of bax and subsequent apoptosis in the proximal colon of guinea pig
40. A genetic model for colorectal tumorigenesis
41. The possible role of probiotics as dietary antimutagens
42. Studies on antimutagenic effect of milk cultured with lactic acid bacteria on the Trp-P2-induced mutagenicity to TA98 strain of Salmonella typhimuriumi
43. Antimutagenicity of components of dairy products
44. Antimutagenicity of lactic acid bacteria from "Idly" against food-related mutagens
45. Antimutagenicity of milk cultured with lactic acid bacteria from Dadih against mutagenic Terasi
46. Antimutagenicity of an acetone extract of yogurt
47. A simple technique for quantitation of low levels of DNA damage in individual cells
48. Induction of DNA damage by risk factors of colon cancer in human colon cells derived from biopsies
49. Effect of pepsin, trypsin or bile acid on the binding of tryptophane pyrolysates by Lactococcus lactis subsp. lactis T-80
50. Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens
51. Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates
52. Nutrition and gut microflora metabolism
53. Anticarcinogenic, hypocholesterolemic, and antagonistic activities of Lactobacillus acidophilus
54. Intestinal bacteria and the hydrolysis of glycoside bonds
55. Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources
56. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans
57. Polyphenols as cancer chemopreventive agents
58. Induction of glutathione-S-transferase-pi by short chain fatty acids in the intestinal cell line caco-2
59. H. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by polyphenolic plant flavonoids
60. Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices
61. Plant flavonoid modulation of immune and inflammatory cell functions
62. Dietary flavonoids, quercetin, luteolin and genistein, reduce oxidative DNA damage and lipid peroxidation and quench free radicals
63. Der einfluss von sauerkraut und kimchi auf bakterielle enzymaktivitäten und den pH-Wert im stuhl des menschen
64. Shift from a mixed diet to a lactovegetarian diet: Influence on some cancer-associated intestinal bacterial enzyme activities
65. Alterations in rat colonic faeces exposed to an acute level of deoxycholate and fed on a nigerian-like diet
66. The carbohydrate crystalean and colonic microflora modulate expression of glutathione S-transferase subunits in colon of rats
67. Potential of short chain fatty acids to modulate the induction of DNA damage and changes in the intracellular calcium concentration in isolated rat colon cells
68. Toxicology of butyrate and short-chain fatty acids